Abstract
Currently there are two main principles for the topical treatment of inflammatory dermatoses. First there are topical glucocorticoids [5] and second there are non-steroidal anti-inflammatory dermatics, e.g. bufexamac, chamomile extract and hamamelis destillate [2, 25]. In recent years there was an increase in the efficacy of topical glucocorticoids due to the introduction of new compounds. Yet, in parallel, there was an increase in unwanted effects, e.g. atrophy of the skin treated and suppression of the hypothalamic-pitui-tary-adrenal axis [5].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aertgeerts J (1984) Erfahrungen mit Kamillosan R, einem standardisierten Kamilleextrakt in der dermatologischen Praxis. Ärztl Kosmetol 14:502–504
Aertgeerts J, Albring M, Klaschka F, Nasemann Th, Patzelt-Wenczler R, Rauhut K, Weigl B (1985) Vergleichende Prüfung von Kamillosan R Creme gegenüber steroidalen (0.25% Hydrocortison, 0.75% Fluocortinbutylester) und nicht-steroidalen (5% Bufexamac) Externa in der Erhaltungstherapie von Ekzemerkrankungen. Zeitschr Hautkr 60:270–277
Agner T (1991) Basal transepidermal water loss, skin thickness, skin blood flow and skin colour in relation to sodium-laurylsulphate-induced irritation in normal skin. Contact Derm 25:108–114
Albring M, Albrecht H, Alcorn G, Lücker PW (1983) The measuring of the antiinflammatory effect of a compound on the skin of volunteers. Meth and Find Clin Pharmacol 5:575–577
Bateman DN (1989) Clinical pharmacology of topical steroids. In: Greaves MW et al (eds) Pharmacology of the Skin II. Springer, Berlin, pp 239–249
Delia Loggia R, Tubaro A, Dri P, Zilli C, Del Negro P (1986) The role of flavonoids in the antiinflammatory activity of Chamomila recutita. Progr Clin Biol Res 213:481–484
Egbaria K, Ramachandran C, Weiner N (1990) Topical delivery of Ciclosporin: Evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. Skin Pharmacol 3:21–28
Egbaria K, Ramachandran C, Weiner N (1991) Topical application of liposomally entrapped Ciclosporin evaluated by in vitro diffusion studies with human skin. Skin Pharmacol 4:21–28
Egbaria K, Weiner N (1990) Liposomes as a topical drug delivery system. Adv Drug Deliv Rev 5:287–300
Farr PM, Diffey BL (1984) Quantitative studies on cutaneous erythema induced by ultraviolet radiation. Brit J Dermatol 11:673–682
Foldvari M, Gesztes A, Mezei M (1990) Dermal drug delivery by liposome encapsulation: Clinical and electron microscopic studies. J Microencapsulation 7:479–489
Habersang S, Leuschner F, Isaac Q, Thiemer K (1979) Pharmakologische Untersuchungen von Kamillen-Inhaltsstoffen. Untersuchungen zur Toxizität des (−)alpha Bisabolols. J Med Plant Res 37:115–123
Hausen BM, Busker E, Carle R (1984) Über das Sensibilisierungsvermögen von Compositenarten. J Med Plant Res 3:205–284
Imokawa G, Akasaki S, Minematsu Y, Kawai M (1989) Importance of intercellular lipids in water-retention properties of the stratum corneum: induction and recovery study of surfactant dry skin. Arch Dermatol Res 281:45–51
Kadir R, Barry BW (1991) Alpha-Bisabolol, a possible safe penetration enhancer for dermal and transdermal therapeutics. Int J Pharm 70:87–94
Kaidbey KH, Kligman AM (1974) Assay of topical corticosteroids by suppression of experimental inflammation in humans. J Invest Dermatol 63:292–297
Korting HC, Zienicke H, Schäfer-Körting M, Braun-Falco O (1990) Liposome enca-pulsation improves efficacy of betamethasone diproprionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 39:349–351
Ljunggren B, Möller H (1973) Influence of corticosteroids on ultraviolet light erythema and pigmentation in man. Arch Dermatol Forsch 248:1–12
Mahjour M, Mauser B, Rashidbaighi Z, Fawzi MB (1990) Effect of egg yolk lecithins and commercial soybean lecithins on in vitro skin permeation of drugs. J Controlled Release 14:243–252
Mc Kenzie SW, Stoughton RB (1962) Method for comparing percutaneous absorption of steroids. Arch Dermatol 86:608–610
Mezei M, Gulasekharam V (1980) Liposomes — a selective drug delivery system for the topical route of administration. Life Sci 26:1473–1477
Niedner R, Johannböcke R (1991) Ausgewählte humanpharmakologische Modelle zur Untersuchung topischer Glukokortikoide. TW Dermatol 21:298–306
Nissen HP, Biltz H, Kreysel HW (1988) Pronlometrie, eine Methode zur Beurteilung der therapeutischen Wirksamkeit von Kamillosan Salbe. Zeitschr Hautkr 63:184–190
Schäfer-Korting M, Korting HC, Braun-Falco O (1989) Liposome preparations: A step forward in topical drug therapy for skin disease? J Am Acad Dermatol 21:1271–1275
Swoboda M, Meurer J (1991) Therapie von Neurodermitis mit Hamamelis-virginiana-Extrakt in Salbenform. Zeitschr Phytother 12:114–117
Wells GC (1957) The effect of hydrocortisone on standardized skin surface trauma. Brit J Dermatol 69:11–18
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kerscher, M.J. (1992). Influence of Liposomal Encapsulation on the Activity of a Herbal Non-steroidal Anti-Inflammatory Drug. In: Braun-Falco, O., Korting, H.C., Maibach, H.I. (eds) Liposome Dermatics. Griesbach Conference. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48391-2_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-48391-2_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55646-6
Online ISBN: 978-3-642-48391-2
eBook Packages: Springer Book Archive